yeah but they much further along in their clinical trials now and they have the support of novartis and there has been a huge increase in institutional support from some big institutions.
desperation! i love it. squeal shorts!!!
Keep squealing shorts!!!
The question you really should be asking is if their pipeline was not so great, why would NVS and TEVA partner with them and why would Orbimed buy a ton of shares last quarter along with other major institutions?
This must be your first time looking at biotechs. You do realize that often bios are valued on potential, not earnings. There are countless number of bio companies with market caps in the multi-billions with no revenues/earnings to speak of. You are obviously new to the game.
Then the partners are impressive because they are fooling all of these smart, experienced, well respected institutions like jennison who are buying tons of shares. Thank goodness there is someone like you to save the day
You're such a little baby with obviously no life and too much time of your hands. Wah, someone spammed a stock, Wah
You really have too much time on your hands. Sad what's become of your life.
Biotech @ValueTraderS 35m35 minutes ago
$SRPT SAREPTA COMPARISON STUDIES OF ETEPLIRSEN SEQUENCE VS DRISAPERSEN SEQUENCE SHOWED UP TO 10-FOLD HIGHER EXON-SKIPPING ACTIVITY 1/2